BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Johns Hopkins-CIDNI - ECPv6.15.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Johns Hopkins-CIDNI
X-ORIGINAL-URL:https://cidni.org
X-WR-CALDESC:Events for Johns Hopkins-CIDNI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221215T140000
DTEND;TZID=America/New_York:20221215T160000
DTSTAMP:20260615T164554
CREATED:20221214T183043Z
LAST-MODIFIED:20221214T183043Z
UID:1351-1671112800-1671120000@cidni.org
SUMMARY:Virtual HIV Treatment and Prevention 2022 Presentation
DESCRIPTION:Please register to hear CIDNI Trainee\, Brenice Duroseau MSN\, FNP-BC\, RNC-OB\, AAHIVS present on Contemporary HIV Treatment and Prevention 2022: Optimizing HIV Outcomes in Challenging Scenarios on December 15\, 2022 at 2pm EST \nContemporary HIV Treatment and Prevention 2022: Optimizing HIV Outcomes in Challenging Scenarios \nThis interactive webinar\, provided in partnership by the Association of Nurses in AIDS Care and Clinical Care Options\, will explore challenging scenarios in HIV care including managing virologic failure in a heavily treatment-experienced patient and switching ART in a virologically suppressed patient with underlying resistance and significant drug–drug interactions. \nWe will invite attendees to share their experiences and perspectives\, and we encourage you to invite fellow ANAC members from your area\, as well as friends and colleagues who are not ANAC members\, to join us. \nFaculty \nRobin Hardwicke\, PhD\, FNP-BC\, AACRN\nNurse Practitioner and Professor\nUT Health Houston\, McGovern Medical School \nBrenice Duroseau\, MSN\, FNP-BC\, RNC-OB\, AAHIVS\nNurse Practitioner and PhD Student\nJohns Hopkins School of Nursing \nDesired Learning Outcomes:  \n· Integrate the latest data on ARV treatment into the individualized care of persons with HIV to overcome virologic failure with multiclass drug resistance\n· Implement best practices in the evidence-based management of ART for patients with extensive treatment history\, comorbidities and/or drug-drug interactions\, and/or suboptimal immune response
URL:https://cidni.org/event/virtual-hiv-treatment-and-prevention-2022-presentation/
CATEGORIES:Workshops & Presentations
END:VEVENT
END:VCALENDAR